What if they do not report by due day, would EAR be delisted? Let’s clap the EAR!
B
Keep shorting and I am adding.
R
$EAR It won't be at these prices for much longer.
#1 Criminal Case was dropped
#2 Has over $4.5 Dollars per share in cash.
#3 Overall Institutional holdings are over 75%
#4 Civil case gives a LOT more room for negotiation and flexibility.
#5 True short interest is at 19% which means over 113% of the public float is being shorted.
#6 There is a true competitive moat, there are no other designs on the market that are even remotely similar to Eargo's they have the only device that is nearly invisible to the naked eye.
#7 Congress is considering adding new hearing benefits to Medicare. The House of Representatives passed an amended version of the Build Back Better Act.
#8 Entire business including cashflow, assets, technologies, patents are currently being valued at $1 per share.
j
Does anyone know when the NASDAQ compliant date is?
א
Basically we are all waiting until the 21th to see where the earnings are... I would love to hear the shorties a decent fundimental explanation of why you do not believe in the stock so we can have a rational discussion
D
Does anyone know when Q3 2021 financials will post? What is the expectation?
J
EAR has potential to go up. Indeed, there are still problems ahead, but $10 is reachable after additional good news.
B
I am adding more. Not play to lose. Let's see, where it goes. Lot of $7.50 calls being bought !
S
Yeahhhh. The just gave a CAO promotion with stay put terms for April and July. Someone is kicking the tires.
G
OTC hearing aids are great.
Company can mass produce - since this is a very niche product will be a huge hit!
This should be in the 20’s already.
No more issue of insurance and very limited target audience.
Due to age factor - everyone losses hearing power and this is very attractive to go and buy on your own such devices.
GL! Gl!
M
shorts soon
B
This is heading way higher. I repeat way higher. It's easy $50+ as compared to IRTC. Watch your steps. BENJO_CHARTS points to $35 with no resistance until 21 !
A
It's looking good folks. I bought at $6.8 today.
L
DOnt know why no analyst upgrade this, after this news.
s
I am holding this stock for long term. I know one morning. There will be a news that civil case also will be dropped. And then we are off to the races. This stock has been beaten up and risk is lower and reward is much higher. Just be patient.
D
Thought on tomorrow
G
SA had an interesting article published back in Oct with two outcome scenarios for the investigation: the collapse of insurance sales; or a decision in favor of Eargo.
For the negative scenario, the company value was $8.8, based on $100 Mio in fines and a take-over by another company.
For the positive scenario, the value estimated by the end of 2025 using the EV/EBITDA method will be $47. By the way, the target multiple of 38.3x is in line with peers Demant and Sonova for future growth.
We are heading into the positive scenario with some nice upside potential.
#1 Criminal Case was dropped
#2 Has over $4.5 Dollars per share in cash.
#3 Overall Institutional holdings are over 75%
#4 Civil case gives a LOT more room for negotiation and flexibility.
#5 True short interest is at 19% which means over 113% of the public float is being shorted.
#6 There is a true competitive moat, there are no other designs on the market that are even remotely similar to Eargo's they have the only device that is nearly invisible to the naked eye.
#7 Congress is considering adding new hearing benefits to Medicare. The House of Representatives passed an amended version of the Build Back Better Act.
#8 Entire business including cashflow, assets, technologies, patents are currently being valued at $1 per share.
I would love to hear the shorties a decent fundimental explanation of why you do not believe in the stock so we can have a rational discussion
Company can mass produce - since this is a very niche product will be a huge hit!
This should be in the 20’s already.
No more issue of insurance and very limited target audience.
Due to age factor - everyone losses hearing power and this is very attractive to go and buy on your own such devices.
GL!
Gl!
And then we are off to the races. This stock has been beaten up and risk is lower and reward is much higher.
Just be patient.
For the negative scenario, the company value was $8.8, based on $100 Mio in fines and a take-over by another company.
For the positive scenario, the value estimated by the end of 2025 using the EV/EBITDA method will be $47.
By the way, the target multiple of 38.3x is in line with peers Demant and Sonova for future growth.
We are heading into the positive scenario with some nice upside potential.